News mentioning insulin
98 stories
Aug 18, 26STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more
Aug 18, 26Amylyx’s bet on a GLP-1 blocker pays off
Aug 18, 26Amylyx eyes FDA filing for GLP-1 blocker after late-stage win in post-bariatric hypoglycemia
Aug 17, 26STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and more
Aug 17, 26STAT+: Kennedy’s split-screen week: Talk of vaccines in D.C., fraud and addiction out West
Aug 13, 26STAT+: Kennedy heads west, slams Becerra
Aug 13, 26STAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and more
Aug 13, 26STAT+: Newsom promotes affordable insulin, but California’s generic label is off to a slow start
Aug 13, 26STAT+: As young people increasingly get cancer, new fertility options are changing their futures
Aug 12, 26Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pill
Aug 4, 26STAT+: Pharmalittle: We’re reading about a Lilly access program, a Gilead court victory, and more